AAPL352.45+0.54 (+0.15%) ▲|ABBV286.01-6.81 (-2.33%) ▼|ABT104.48-0.23 (-0.22%) ▼|ACN227.49-11.79 (-4.93%) ▼|ADBE226.20-9.35 (-3.97%) ▼|AMAT352.30+3.07 (+0.88%) ▲|AMD530.14+26.73 (+5.31%) ▲|AMGN443.89-14.04 (-3.07%) ▼|AMT184.82+1.64 (+0.90%) ▲|AMZN267.74+9.85 (+3.82%) ▲|AVGO354.05+12.45 (+3.64%) ▲|AXP315.40-0.38 (-0.12%) ▼|BA162.91-1.00 (-0.61%) ▼|BAC48.91-0.53 (-1.07%) ▼|BKNG153.28-1.18 (-0.76%) ▼|BLK1,169.21-11.46 (-0.97%) ▼|BMY59.56-1.79 (-2.92%) ▼|BNY147.80-1.99 (-1.33%) ▼|BRK-B574.62-12.14 (-2.07%) ▼|C117.34-2.60 (-2.17%) ▼|CAT558.77-12.02 (-2.11%) ▼|CL98.85-0.76 (-0.76%) ▼|CMCSA25.24-0.07 (-0.28%) ▼|COF184.30-2.48 (-1.33%) ▼|COP134.40-5.08 (-3.64%) ▼|COST1,096.62-13.46 (-1.21%) ▼|CRM190.40-4.12 (-2.12%) ▼|CSCO97.18+2.07 (+2.18%) ▲|CVS81.35-4.46 (-5.20%) ▼|CVX205.88-8.47 (-3.95%) ▼|DE644.75-4.48 (-0.69%) ▼|DHR228.58+2.81 (+1.24%) ▲|DIS122.36+5.42 (+4.63%) ▲|DUK130.05+0.21 (+0.16%) ▲|EMR162.00+2.85 (+1.79%) ▲|FDX318.31-1.63 (-0.51%) ▼|GD349.04-6.59 (-1.85%) ▼|GE328.10+1.70 (+0.52%) ▲|GEV772.22-7.69 (-0.99%) ▼|GILD168.98-1.28 (-0.75%) ▼|GM82.13-1.92 (-2.28%) ▼|GOOG279.20+1.60 (+0.58%) ▲|GOOGL282.44+2.24 (+0.80%) ▲|GS873.18-4.34 (-0.49%) ▼|HD337.64-1.37 (-0.40%) ▼|HON222.70+3.74 (+1.71%) ▲|IBM228.53-2.56 (-1.11%) ▼|INTC54.67-0.50 (-0.91%) ▼|INTU313.24-7.55 (-2.35%) ▼|ISRG420.95-9.58 (-2.23%) ▼|JNJ272.70-6.00 (-2.15%) ▼|JPM324.11-5.85 (-1.77%) ▼|KO98.09-0.70 (-0.71%) ▼|LIN512.16-2.95 (-0.57%) ▼|LLY1,382.75-32.80 (-2.32%) ▼|LMT578.19-12.15 (-2.06%) ▼|LOW222.78+2.32 (+1.05%) ▲|LRCX211.67+0.98 (+0.47%) ▲|MA643.37-2.36 (-0.37%) ▼|MCD274.03-1.79 (-0.65%) ▼|MDLZ66.57-0.19 (-0.28%) ▼|MDT100.72-1.60 (-1.56%) ▼|META616.38-2.49 (-0.40%) ▼|MMM181.05+0.17 (+0.09%) ▲|MO76.26-1.20 (-1.55%) ▼|MRK137.78-5.59 (-3.90%) ▼|MS181.17-2.36 (-1.29%) ▼|MSFT508.29+2.05 (+0.40%) ▲|MU705.27-7.15 (-1.00%) ▼|NEE84.78+0.36 (+0.43%) ▲|NFLX59.82+0.14 (+0.23%) ▲|NKE36.31+0.46 (+1.28%) ▲|NOW90.59-2.31 (-2.49%) ▼|NVDA150.96-4.50 (-2.89%) ▼|ORCL113.89-1.11 (-0.97%) ▼|PEP141.87-0.15 (-0.11%) ▼|PFE28.06-0.41 (-1.44%) ▼|PG170.29-1.43 (-0.83%) ▼|PLTR156.67+0.11 (+0.07%) ▲|PM192.73-1.65 (-0.85%) ▼|QCOM159.81-6.86 (-4.12%) ▼|RTX197.45-0.55 (-0.28%) ▼|SBUX109.11+1.62 (+1.51%) ▲|SCHW92.56+0.72 (+0.78%) ▲|SO94.41+0.81 (+0.87%) ▲|SPG231.38+1.14 (+0.50%) ▲|T21.95-0.34 (-1.53%) ▼|TMO692.74+5.95 (+0.87%) ▲|TMUS164.02-3.88 (-2.31%) ▼|TSLA383.72+3.61 (+0.95%) ▲|TXN292.43-3.43 (-1.16%) ▼|UBER68.76-0.05 (-0.07%) ▼|UNH349.91-39.77 (-10.21%) ▼|UNP300.90+3.87 (+1.30%) ▲|UPS111.03+0.72 (+0.65%) ▲|USB58.28-0.90 (-1.52%) ▼|V415.22-1.55 (-0.37%) ▼|VZ46.13+0.20 (+0.44%) ▲|WFC80.92-1.77 (-2.14%) ▼|WMT127.36-0.16 (-0.13%) ▼|XOM160.58-6.63 (-3.97%) ▼|AAPL352.45+0.54 (+0.15%) ▲|ABBV286.01-6.81 (-2.33%) ▼|ABT104.48-0.23 (-0.22%) ▼|ACN227.49-11.79 (-4.93%) ▼|ADBE226.20-9.35 (-3.97%) ▼|AMAT352.30+3.07 (+0.88%) ▲|AMD530.14+26.73 (+5.31%) ▲|AMGN443.89-14.04 (-3.07%) ▼|AMT184.82+1.64 (+0.90%) ▲|AMZN267.74+9.85 (+3.82%) ▲|AVGO354.05+12.45 (+3.64%) ▲|AXP315.40-0.38 (-0.12%) ▼|BA162.91-1.00 (-0.61%) ▼|BAC48.91-0.53 (-1.07%) ▼|BKNG153.28-1.18 (-0.76%) ▼|BLK1,169.21-11.46 (-0.97%) ▼|BMY59.56-1.79 (-2.92%) ▼|BNY147.80-1.99 (-1.33%) ▼|BRK-B574.62-12.14 (-2.07%) ▼|C117.34-2.60 (-2.17%) ▼|CAT558.77-12.02 (-2.11%) ▼|CL98.85-0.76 (-0.76%) ▼|CMCSA25.24-0.07 (-0.28%) ▼|COF184.30-2.48 (-1.33%) ▼|COP134.40-5.08 (-3.64%) ▼|COST1,096.62-13.46 (-1.21%) ▼|CRM190.40-4.12 (-2.12%) ▼|CSCO97.18+2.07 (+2.18%) ▲|CVS81.35-4.46 (-5.20%) ▼|CVX205.88-8.47 (-3.95%) ▼|DE644.75-4.48 (-0.69%) ▼|DHR228.58+2.81 (+1.24%) ▲|DIS122.36+5.42 (+4.63%) ▲|DUK130.05+0.21 (+0.16%) ▲|EMR162.00+2.85 (+1.79%) ▲|FDX318.31-1.63 (-0.51%) ▼|GD349.04-6.59 (-1.85%) ▼|GE328.10+1.70 (+0.52%) ▲|GEV772.22-7.69 (-0.99%) ▼|GILD168.98-1.28 (-0.75%) ▼|GM82.13-1.92 (-2.28%) ▼|GOOG279.20+1.60 (+0.58%) ▲|GOOGL282.44+2.24 (+0.80%) ▲|GS873.18-4.34 (-0.49%) ▼|HD337.64-1.37 (-0.40%) ▼|HON222.70+3.74 (+1.71%) ▲|IBM228.53-2.56 (-1.11%) ▼|INTC54.67-0.50 (-0.91%) ▼|INTU313.24-7.55 (-2.35%) ▼|ISRG420.95-9.58 (-2.23%) ▼|JNJ272.70-6.00 (-2.15%) ▼|JPM324.11-5.85 (-1.77%) ▼|KO98.09-0.70 (-0.71%) ▼|LIN512.16-2.95 (-0.57%) ▼|LLY1,382.75-32.80 (-2.32%) ▼|LMT578.19-12.15 (-2.06%) ▼|LOW222.78+2.32 (+1.05%) ▲|LRCX211.67+0.98 (+0.47%) ▲|MA643.37-2.36 (-0.37%) ▼|MCD274.03-1.79 (-0.65%) ▼|MDLZ66.57-0.19 (-0.28%) ▼|MDT100.72-1.60 (-1.56%) ▼|META616.38-2.49 (-0.40%) ▼|MMM181.05+0.17 (+0.09%) ▲|MO76.26-1.20 (-1.55%) ▼|MRK137.78-5.59 (-3.90%) ▼|MS181.17-2.36 (-1.29%) ▼|MSFT508.29+2.05 (+0.40%) ▲|MU705.27-7.15 (-1.00%) ▼|NEE84.78+0.36 (+0.43%) ▲|NFLX59.82+0.14 (+0.23%) ▲|NKE36.31+0.46 (+1.28%) ▲|NOW90.59-2.31 (-2.49%) ▼|NVDA150.96-4.50 (-2.89%) ▼|ORCL113.89-1.11 (-0.97%) ▼|PEP141.87-0.15 (-0.11%) ▼|PFE28.06-0.41 (-1.44%) ▼|PG170.29-1.43 (-0.83%) ▼|PLTR156.67+0.11 (+0.07%) ▲|PM192.73-1.65 (-0.85%) ▼|QCOM159.81-6.86 (-4.12%) ▼|RTX197.45-0.55 (-0.28%) ▼|SBUX109.11+1.62 (+1.51%) ▲|SCHW92.56+0.72 (+0.78%) ▲|SO94.41+0.81 (+0.87%) ▲|SPG231.38+1.14 (+0.50%) ▲|T21.95-0.34 (-1.53%) ▼|TMO692.74+5.95 (+0.87%) ▲|TMUS164.02-3.88 (-2.31%) ▼|TSLA383.72+3.61 (+0.95%) ▲|TXN292.43-3.43 (-1.16%) ▼|UBER68.76-0.05 (-0.07%) ▼|UNH349.91-39.77 (-10.21%) ▼|UNP300.90+3.87 (+1.30%) ▲|UPS111.03+0.72 (+0.65%) ▲|USB58.28-0.90 (-1.52%) ▼|V415.22-1.55 (-0.37%) ▼|VZ46.13+0.20 (+0.44%) ▲|WFC80.92-1.77 (-2.14%) ▼|WMT127.36-0.16 (-0.13%) ▼|XOM160.58-6.63 (-3.97%) ▼|
13.4 C
New York
Thursday, November 19, 2026

Tag: FOR

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Broadmark Realty Capital Inc. of Class Action Lawsuit and Upcoming Deadlines...

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Broadmark Realty Capital Inc. ("Broadmark"...

Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or the "Company")...

Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortrea Holdings, Inc. ("Fortrea" or the...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. – NPCE

NEW YORK, June 22, 2025 /PRNewswire/ -- APomerantz LLP is investigating claims on behalf of investors of  NeuroPace, Inc. ("NeuroPace" or the "Company") (NASDAQ:...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation – DDD

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  3D Systems Corporation ("3D Systems" or the...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. – RCKT

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company")...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sable Offshore Corp. – SOC

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sable Offshore Corp. ("Sable" or the "Company")...

“The Most Important Thing About Art is Freedom,” says AR Rahman at IGF London 2025

Oscar-winning composer on scent cinema, AI, and the reinvention of Indian music culture LONDON, June 22, 2025 /PRNewswire/ --  In a deeply personal and expansive...

RICH Miner Announces Global Expansion and Zero-Hassle Cloud Mining for Robinhood Users

London, UK, June 22, 2025 (GLOBE NEWSWIRE) -- RICH Miner, an intelligent cloud mining platform, has officially announced its global expansion and enhanced features, making it easier than ever for Robinhood users and crypto investors worldwide to earn daily passive income through clean-energy cloud mining.

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published...

Bagsværd, Denmark, 22 June – Today, The New England Journal of Medicine (NEJM) published results from Novo Nordisk’s phase 3 REDEFINE 1 trial evaluating the efficacy and safety of investigational CagriSema plus lifestyle interventions for weight loss in adults with obesity or overweight who have a weight-related medical complication and without diabetes.1 REDEFINE 1 met its co-primary endpoints and achieved statistically significant and clinically meaningful weight loss at 68 weeks in patients taking CagriSema versus placebo.1 These data, along with the related phase 3 REDEFINE 2 study conducted in adults with overweight or obesity and type 2 diabetes, were presented today during a scientific symposium at the American Diabetes Association’s (ADA) 85th Scientific Sessions and published in NEJM.

CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM

Data presented simultaneously at the American Diabetes Association's® 85th Scientific Sessions, showed mean weight reduction in the highest range of efficacy observed with existing...

CagriSema Demonstrates Significant Weight Loss in Adults with Obesity

Once-weekly medication results in weight loss of up to 22.7% in adults without diabetes and 15.7% in those with type 2 diabetes CHICAGO, June 22,...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”), of the important August 11, 2025 lead plaintiff deadline.

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility and actionable intelligence DENVER, June 22, 2025 /PRNewswire/ --...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFOR